Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) France
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
3 | 0.80 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 3 | 0.80 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.19 | 0.42 | 0.16 | 0.52 | 0.05 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 80.33% Domestic
- 19.67% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) by Share (22 total)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and National Institute for Health and Medical Research (INSERM)
(1.32)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Rennes 1
(1.08)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Etablissement Français du Sang (EFS)
(1.07)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and French National Centre for Scientific Research (CNRS)
(0.90)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Montpellier
(0.82)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and ICGex
(0.68)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Rennes University Hospital (CHU Rennes)
(0.65)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Curie Institute
(0.64)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Biology and Health Federative Research Strcuture of Rennes (Biosit)
(0.63)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Ligue Contre Le Cancer
(0.62)
Top 10 international collaborators with Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) by Share (18 total)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Toronto (U of T)
(0.65)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Memorial Sloan Kettering Cancer Center (MSKCC)
(0.63)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Sussex
(0.29)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Institute for the Study and Prevention of Cancer (ISPRO)
(0.24)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and National Research Council (CNR)
(0.21)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Siena (UNISI)
(0.21)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and University of Montreal (UdeM)
(0.12)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Montreal Cancer Institute (ICM)
(0.09)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and F. Hoffmann-La Roche AG
(0.08)
-
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) and Institutos Nacionais de Ciência e Teconologia de Investigação em Imunologia (iii-INCT)
(0.08)
Relationships
Partner Institutions
Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.